Package 70771-1673-3

{"route": ["ORAL"], "spl_id": "eb40db9e-ddc1-4041-aac5-ff0f2c478fc6", "openfda": {"nui": ["N0000182961", "N0000182960"], "unii": ["0P6C6ZOP5U"], "rxcui": ["1091839", "2001319"], "spl_set_id": ["e87287bd-eae3-46c3-9072-04800aeabf40"], "pharm_class_epc": ["Phosphodiesterase 4 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 4 Inhibitors [MoA]"], "manufacturer_name": ["Zydus Lifesciences Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BLISTER PACK in 1 CARTON (70771-1673-3)  / 10 TABLET in 1 BLISTER PACK (70771-1673-2)", "package_ndc": "70771-1673-3", "marketing_start_date": "20230518"}, {"sample": false, "description": "1 BLISTER PACK in 1 CARTON (70771-1673-8)  / 28 TABLET in 1 BLISTER PACK", "package_ndc": "70771-1673-8", "marketing_start_date": "20230518"}], "brand_name": "Roflumilast", "product_id": "70771-1673_eb40db9e-ddc1-4041-aac5-ff0f2c478fc6", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 4 Inhibitor [EPC]", "Phosphodiesterase 4 Inhibitors [MoA]"], "product_ndc": "70771-1673", "generic_name": "Roflumilast", "labeler_name": "Zydus Lifesciences Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Roflumilast", "active_ingredients": [{"name": "ROFLUMILAST", "strength": "250 ug/1"}], "application_number": "ANDA208303", "marketing_category": "ANDA", "marketing_start_date": "20230518", "listing_expiration_date": "20261231"}